◆英語タイトル:Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5335
◆発行会社(調査会社):
GlobalData
◆発行日:2018年9月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Merrimack Pharmaceuticals Inc (MACK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (marketed chemotherapy drug) in a liposomal formulation used in the treatment of pancreatic metastatic adenocarcinoma. Its pipeline portfolio includes investigational candidates targeted at the treatment of advanced non-small cell lung cancer (NSCLC), solid tumors, metastatic breast cancer, and heregulin positive breast cancer. The company sells its products through a network of distributors in the US. Merrimack is headquartered in Cambridge, Massachusetts, the US.
Merrimack Pharmaceuticals Inc Key Recent Developments
Aug 07,2018: Merrimack reports second quarter 2018 financial results
Jul 02,2018: Merrimack Secures $25 Million Debt Facility with Hercules Capital
May 23,2018: Merrimack is recognized in Harvard Business School/Kraft Precision Trials Challenge
May 08,2018: Merrimack Reports First Quarter 2018 Financial Results
Mar 12,2018: Merrimack Reports 2017 Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Merrimack Pharmaceuticals Inc – Key Facts 6
Merrimack Pharmaceuticals Inc – Key Employees 7
Merrimack Pharmaceuticals Inc – Key Employee Biographies 8
Merrimack Pharmaceuticals Inc – Major Products and Services 9
Merrimack Pharmaceuticals Inc – History 10
Merrimack Pharmaceuticals Inc – Company Statement 11
Merrimack Pharmaceuticals Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Merrimack Pharmaceuticals Inc – Business Description 16
R&D Overview 16
Merrimack Pharmaceuticals Inc – SWOT Analysis 17
SWOT Analysis – Overview 17
Merrimack Pharmaceuticals Inc – Strengths 17
Merrimack Pharmaceuticals Inc – Weaknesses 18
Merrimack Pharmaceuticals Inc – Opportunities 19
Merrimack Pharmaceuticals Inc – Threats 20
Merrimack Pharmaceuticals Inc – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Merrimack Pharmaceuticals Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Aug 07, 2018: Merrimack reports second quarter 2018 financial results 31
Aug 07, 2018: Merrimack reports second quarter 2018 financial results 33
Aug 07, 2018: Merrimack reports second quarter 2018 financial results 35
Aug 07, 2018: Merrimack reports second quarter 2018 financial results 37
Jul 02, 2018: Merrimack Secures $25 Million Debt Facility with Hercules Capital 39
May 23, 2018: Merrimack is recognized in Harvard Business School/Kraft Precision Trials Challenge 40
May 23, 2018: Merrimack is recognized in Harvard Business School/Kraft Precision Trials Challenge 41
May 08, 2018: Merrimack Reports First Quarter 2018 Financial Results 42
Feb 20, 2018: Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology 43
Nov 30, 2017: Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors 44
Section 6 – Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
Merrimack Pharmaceuticals Inc, Key Facts 6
Merrimack Pharmaceuticals Inc, Key Employees 7
Merrimack Pharmaceuticals Inc, Key Employee Biographies 8
Merrimack Pharmaceuticals Inc, Major Products and Services 9
Merrimack Pharmaceuticals Inc, History 10
Merrimack Pharmaceuticals Inc, Subsidiaries 14
Merrimack Pharmaceuticals Inc, Key Competitors 21
Merrimack Pharmaceuticals Inc, Ratios based on current share price 22
Merrimack Pharmaceuticals Inc, Annual Ratios 23
Merrimack Pharmaceuticals Inc, Annual Ratios (Cont...1) 24
Merrimack Pharmaceuticals Inc, Interim Ratios 26
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Merrimack Pharmaceuticals Inc, Recent Deals Summary 30
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48
List of Figures
Merrimack Pharmaceuticals Inc, Performance Chart (2013 - 2017) 25
Merrimack Pharmaceuticals Inc, Ratio Charts 27
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29